Metabolomic Profiles Differentiate Scleroderma-PAH From Idiopathic PAH and Correspond With Worsened Functional Capacity.

Mona Alotaibi, Junzhe Shao,Michael W Pauciulo,William C Nichols,Anna R Hemnes,Atul Malhotra,Nick H Kim,Jason X-J Yuan,Timothy Fernandes,Kim M Kerr,Laith Alshawabkeh,Ankit A Desai,Andreea M Bujor,Robert Lafyatis,Jeramie D Watrous,Tao Long,Susan Cheng,Stephen Y Chan,Mohit Jain

Chest（2023）

引用 3|浏览46

暂无评分

摘要

Patients with SSc-PAH are characterized by an unfavorable bioactive metabolic profile that may explain the poor and limited response to therapy. These data provide important metabolic insights into the molecular heterogeneity underlying differences between subgroups of PAH.

查看译文

关键词

biomarkers,metabolomics,pulmonary hypertension,scleroderma

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要